Drug Flashcards

1
Q

What are presynaptic events, and how do drugs affect them to produce their effects?

A

Key Findings:
• Presynaptic Events (突触前事件):
• These are steps that occur in the presynaptic neuron before neurotransmitter release, including:
• Synthesis of neurotransmitters
• Storage in vesicles
• Vesicle docking and fusion
• Release into synaptic cleft upon arrival of an action potential
• How Drugs Affect Presynaptic Events:
• Altering NT Synthesis: Drugs can increase or block the production of neurotransmitters.
• Example: L-DOPA boosts dopamine production.
• Blocking Vesicle Transport or Release:
• Example: Reserpine interferes with vesicle storage of monoamines.
• Enhancing NT Release:
• Example: Amphetamines cause excessive dopamine release.
• Blocking Autoreceptors (which normally reduce NT release):
• Increases NT output by removing feedback inhibition.
• Modulating Presynaptic Calcium Channels:
• Drugs can enhance or inhibit calcium influx, which directly affects vesicle fusion and NT release.

Key Takeaway:
• Drugs can modify presynaptic events by altering neurotransmitter synthesis, storage, and release—ultimately changing how much and how often neurotransmitters reach the postsynaptic cell, producing therapeutic or psychoactive effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do specific drugs affect neurotransmitter release by targeting presynaptic mechanisms?

A

Key Findings:
• Blocking Na⁺ Channels → Prevent Action Potentials
• Tetrodotoxin (TTX):
• Found in pufferfish.
• Blocks voltage-gated Na⁺ channels, preventing action potential propagation.
• Result: No depolarization, so no NT release.
• Novocain (局部麻醉剂):
• Blocks Na⁺ channels locally.
• Prevents sensory neuron signals from firing, leading to localized numbness.
• Blocking Ca²⁺ Entry → Prevent Vesicle Fusion & NT Release
• Calcium channels are essential for triggering vesicle fusion and neurotransmitter release.
• Blocking these channels stops NT from being released even if an AP arrives.
• Botox (Botulinum Toxin):
• Blocks vesicle fusion machinery (SNARE proteins) in acetylcholine neurons.
• Prevents ACh release at neuromuscular junctions.
• Result: Paralysis of muscles (used cosmetically and medically).
• Tetanus Toxin:
• Released by Clostridium tetani (破伤风菌).
• Blocks inhibitory neurotransmitter (e.g., GABA) release from spinal interneurons.
• Result: Uncontrolled motor neuron firing → severe muscle spasms.

Key Takeaway:
• Drugs and toxins like TTX, Novocain, Botox, and tetanus interfere with neurotransmitter release by blocking Na⁺/Ca²⁺ channels or vesicle fusion, leading to paralysis, numbness, or excessive motor activity depending on the target.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are autoreceptors, and how do drugs like caffeine affect neurotransmitter release through them?

A

Key Findings:
• Autoreceptors (自体受体):
• Located on the presynaptic neuron.
• Function as a feedback mechanism—they monitor and regulate how much neurotransmitter is being released.
• When activated by their own neurotransmitter, they typically inhibit further release to maintain balance.
• Stimulation of Autoreceptors → Inhibition of Release
• Example: When serotonin binds to its own autoreceptors, the presynaptic neuron reduces further serotonin release.
• This is a self-regulating mechanism to prevent overstimulation.
• Blocking Autoreceptors → Increased NT Release
• If a drug blocks these autoreceptors, it removes the inhibition, causing the presynaptic neuron to release more neurotransmitter.
• This can enhance signaling, especially with repeated stimulation.
• Caffeine:
• Acts as a stimulant by blocking adenosine receptors, which normally inhibit neurotransmitter release.
• By blocking adenosine, caffeine leads to increased dopamine and norepinephrine release, promoting alertness and arousal.
• It does not act on autoreceptors directly, but removes inhibitory tone from another regulatory system.

Key Takeaway:
• Autoreceptors help regulate neurotransmitter release via feedback inhibition. Blocking them (or similar inhibitory systems like adenosine with caffeine) leads to increased NT release and greater synaptic activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is neurotransmitter clearance, and how do drugs affect it through transporter blockade and degradation enzymes like acetylcholinesterase?

A

Key Findings:
• Clearance (清除作用):
• After neurotransmitters are released into the synaptic cleft, they must be cleared to stop signaling and reset the synapse.
• Two main clearance mechanisms:
1. Reuptake by transporters (转运体回收)
2. Enzymatic degradation (酶解降解)

•	Block Transporters → Prolong NT Action
•	Transporters on the presynaptic terminal reabsorb neurotransmitters for reuse or breakdown.
•	Blocking these transporters leads to more NT in the synaptic cleft, enhancing its effect.
•	Examples:
•	SSRIs (选择性5-羟色胺再摄取抑制剂): Block serotonin reuptake → treat depression.
•	Cocaine and amphetamines: Block dopamine reuptake → increase euphoria and arousal.

•	Enzymatic Degradation → Inactivate NT
•	Enzymes in the synapse break down neurotransmitters, stopping their action.
•	Acetylcholinesterase (AChE):
•	Breaks down acetylcholine (ACh) in the synaptic cleft into acetate + choline.
•	This is crucial for ending muscle contraction signals at neuromuscular junctions.
•	AChE inhibitors (e.g., used in Alzheimer’s treatment) increase ACh availability to improve cognition.

Key Takeaway:
• Clearance of neurotransmitters occurs via reuptake or enzymatic degradation. Drugs can block transporters or enzymes like acetylcholinesterase to prolong or intensify neurotransmitter effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are postsynaptic events, and how can drugs in the central nervous system (CNS) affect these cellular processes?

A

Key Findings:
• Postsynaptic Events (突触后事件):
• Begin when neurotransmitters bind to receptors on the postsynaptic membrane.
• This triggers changes such as:
• Opening ion channels → alters membrane potential (e.g., EPSPs or IPSPs)
• Activating second messengers → triggers longer-term intracellular effects
• Gene expression changes → affects receptor density, protein production

•	How CNS Drugs Affect Postsynaptic Events:
•	Mimic neurotransmitters (agonists) → activate postsynaptic receptors directly.
•	Block receptors (antagonists) → prevent neurotransmitter binding and action.
•	Modulate receptor sensitivity → enhance or reduce receptor response to NTs.
•	Act on intracellular signaling pathways:
•	Affect second messengers like cAMP or calcium.
•	Alter gene transcription and protein synthesis, changing neuronal structure/function.

•	Cellular-Level Effects:
•	Changes in receptor number (upregulation/downregulation)
•	Synaptic plasticity (long-term potentiation or depression)
•	Altered excitability of the neuron
•	In long-term use, CNS drugs may lead to neural circuit remodeling or tolerance.

Key Takeaway:
• Postsynaptic events involve receptor activation, ion flow, and intracellular signaling. CNS drugs can enhance or inhibit these processes, producing short-term effects (like excitation/inhibition) and long-term changes (like plasticity or tolerance).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do agonists and antagonists affect neurotransmitter receptors?

A

Key Findings:
• Agonists (激动剂):
• Mimic the natural neurotransmitter by binding to its receptor and activating it.
• Can produce the same or even a stronger effect than the endogenous transmitter.
• Example:
• Morphine → Agonist at opioid receptors → Produces pain relief and euphoria.
• Nicotine → Agonist at nicotinic acetylcholine receptors → Stimulates alertness and attention.
• Antagonists (拮抗剂):
• Bind to the receptor but do not activate it.
• Instead, they block the natural neurotransmitter from binding, reducing or preventing receptor activation.
• Example:
• Haloperidol → Dopamine antagonist → Used to treat schizophrenia by reducing dopamine signaling.
• Curare → ACh receptor antagonist → Causes paralysis by blocking neuromuscular transmission.

Key Takeaway:
• Agonists activate neurotransmitter receptors to enhance signaling, while antagonists block receptors to reduce or prevent neurotransmitter effects. Both types of drugs are crucial in modulating brain function for therapeutic or psychoactive outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What intracellular processes do drugs affect, and how does lithium chloride work?

A

Key Findings:
• Intracellular Processes (细胞内过程):
• After a neurotransmitter or drug binds to a postsynaptic receptor, it can activate intracellular signaling cascades, especially through metabotropic receptors (G-protein-coupled).
• These processes include:
• Second messengers (e.g., cAMP, IP3) → amplify the signal inside the cell.
• Activation of protein kinases → modify proteins to alter cell function.
• Changes in gene expression → affect long-term neuronal structure and behavior.
• Regulation of receptor sensitivity and synaptic plasticity.

•	Lithium Chloride (LiCl):
•	A mood stabilizer, commonly used to treat bipolar disorder.
•	It works by modulating intracellular signaling, especially in neurons involved in mood regulation.
•	Mechanisms include:
•	Inhibiting second messenger pathways (e.g., inositol phosphate system).
•	Altering gene expression and neuroplasticity over time.
•	Stabilizing neuronal activity to reduce extreme mood swings.

Key Takeaway:
• Drugs can influence intracellular processes like second messenger signaling and gene expression. Lithium chloride acts within neurons to stabilize mood by modulating these internal pathways, especially in bipolar disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are DREADDs, and how are they used in neuroscience research?

A

Key Findings:
• What Are DREADDs?
• DREADDs are genetically engineered receptors that do not respond to natural neurotransmitters, but can be activated by synthetic (designer) drugs.
• The most commonly used designer drug is CNO (clozapine-N-oxide).
• Purpose:
• Used to selectively control the activity of specific neurons in live animals.
• Researchers insert DREADDs into targeted brain regions via gene delivery (e.g., viral vectors).
• Administering CNO will activate or inhibit only the neurons with DREADDs, allowing precise, reversible control.
• Types of DREADDs:
• Excitatory DREADDs → Activate neurons when CNO is applied.
• Inhibitory DREADDs → Silence neurons when activated.
• Applications:
• Studying specific circuits in behavior, emotion, addiction, memory, etc.
• Offers non-invasive, reversible, and cell-type-specific manipulation.

Key Takeaway:
• DREADDs are engineered receptors activated only by synthetic drugs, enabling researchers to precisely and reversibly control specific neurons and study their roles in brain function and behavior.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are optogenetics and DREADDs similar, and how do they differ in neuroscience research?

A

Key Findings:
• Shared Purpose:
• Both optogenetics and DREADDs are powerful techniques used to precisely control specific neurons in the brain.
• Allow researchers to study how specific circuits contribute to behavior, emotion, learning, and disease.

•	DREADDs (化学遗传学工具):
•	Slower, long-lasting control (minutes to hours).
•	Uses engineered receptors activated by designer drugs (e.g., CNO).
•	Non-invasive once delivered—drug can be administered systemically.
•	Ideal for studying longer-term behavioral effects.
•	Optogenetics (光遗传学工具):
•	Fast, precise control (millisecond resolution).
•	Uses light-sensitive ion channels (e.g., channelrhodopsin) introduced into neurons.
•	Requires surgical implantation of fiber optics to shine light on the target brain area.
•	Ideal for studying rapid neural dynamics and timing in real time.

Key Takeaway:
• DREADDs and optogenetics both allow targeted control of neurons, but DREADDs use designer drugs for slow, sustained modulation, while optogenetics uses light for fast, precise activation or inhibition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are key neuroscience breakthroughs in treating mental disorders over the past 70 years?

A

Key Findings:
• Neuroscience has revealed that mental disorders arise from brain dysfunction, not just behavior.
• This led to the development of targeted drug treatments, including:
• First-generation antipsychotics (e.g., chlorpromazine) → treat positive symptoms of schizophrenia, like hallucinations.
• Second-generation antipsychotics → also address negative symptoms (e.g., social withdrawal), with fewer motor side effects.
• Antidepressants (e.g., SSRIs) and mood stabilizers (e.g., lithium) for depression and bipolar disorder.
• These advances shifted psychiatry toward a biological model and opened the door to modern brain-based therapies.

Key Takeaway:
• Neuroscience has enabled drug-based treatments for mental illness, from first- and second-generation antipsychotics to antidepressants—redefining mental health as a brain-based condition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are antidepressants, and how do they work?

A

Key Findings:
• Antidepressants (抗抑郁药) are drugs used to treat depression, as well as anxiety disorders, OCD, and PTSD.
• They work by increasing the availability of neurotransmitters (especially serotonin, norepinephrine, and dopamine) in the brain to improve mood and emotional regulation.

•	Major Types of Antidepressants:
•	SSRIs (选择性5-羟色胺再摄取抑制剂)
•	Block reuptake of serotonin → more remains in the synapse.
•	Example: Prozac, Zoloft
•	SNRIs (5-羟色胺-去甲肾上腺素再摄取抑制剂)
•	Block reuptake of serotonin and norepinephrine.
•	MAOIs (单胺氧化酶抑制剂)
•	Inhibit the enzyme that breaks down monoamines → increases all monoamines.
•	Tricyclic Antidepressants (三环类抗抑郁药)
•	Older drugs that block reuptake of several NTs, but with more side effects.

Key Takeaway:
• Antidepressants treat mood disorders by boosting key neurotransmitters in the brain, especially serotonin. Different classes target different mechanisms to restore emotional balance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are tricyclic antidepressants, SSRIs, and SNRIs, and how do they differ?

A

Key Findings:
• Tricyclic Antidepressants (TCAs, 三环类抗抑郁药)
• Block reuptake of serotonin and norepinephrine, increasing both in the synapse.
• Also affect other receptors (e.g., histamine, acetylcholine), causing more side effects.
• Examples: Amitriptyline, Imipramine
• Side effects: sedation, dry mouth, weight gain, heart arrhythmias.
• Selective Serotonin Reuptake Inhibitors (SSRIs, 选择性5-羟色胺再摄取抑制剂)
• Block only serotonin reuptake, increasing serotonin levels in a more targeted way.
• Fewer side effects, better tolerated.
• Examples: Prozac (fluoxetine), Zoloft (sertraline)
• Side effects: insomnia, nausea, sexual dysfunction.
• Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs, 5-羟色胺–去甲肾上腺素再摄取抑制剂)
• Block reuptake of both serotonin and norepinephrine, similar to TCAs but more selective.
• Designed to provide dual-action relief for depression and anxiety with fewer side effects than TCAs.
• Examples: Effexor (venlafaxine), Cymbalta (duloxetine)

Key Takeaway:
• TCAs, SSRIs, and SNRIs all increase monoamine levels but differ in selectivity and side effects. SSRIs are most selective (serotonin only), SNRIs target two systems with fewer side effects than TCAs, which are broader but less tolerable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are depressants, and how do anxiolytics, barbiturates, and benzodiazepines like alprazolam and lorazepam work?

A

Key Findings:
• Depressants (抑制剂类药物):
• Drugs that reduce nervous system activity, producing calming, anti-anxiety, or sedative effects.
• Used to treat anxiety, insomnia, seizures, and sometimes for anesthesia.

•	Anxiolytics (抗焦虑药):
•	General term for drugs that reduce anxiety.
•	Most common type: Benzodiazepines.
•	Barbiturates (巴比妥类):
•	Older class of depressants.
•	Enhance GABA-A receptor activity → Increase inhibition in the brain.
•	Risky: Narrow therapeutic window → high overdose and dependence potential.
•	Largely replaced by safer benzodiazepines.
•	Benzodiazepine Agonists (苯二氮卓激动剂):
•	Bind to GABA-A receptors, enhancing GABA’s inhibitory effect.
•	Safer than barbiturates, widely used to treat anxiety, panic, and insomnia.
•	Do not directly activate the receptor but increase the effect of GABA.
•	Examples:
•	Alprazolam (Xanax) → fast-acting anti-anxiety med.
•	Lorazepam (Ativan) → used for anxiety, seizures, and sedation.

Key Takeaway:
• Depressants like benzodiazepines and barbiturates reduce brain activity by enhancing GABA signaling. Benzodiazepines like alprazolam and lorazepam are widely used anxiolytics with lower overdose risk than barbiturates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do GABA receptors function, and what roles do orphan receptors, allopregnanolone, and neurosteroids play?

A

Key Findings:
• GABA-A Receptors (γ-氨基丁酸A受体):
• Ionotropic receptors that allow Cl⁻ (chloride) ions into the neuron → hyperpolarization (makes neuron less likely to fire).
• Main target of depressants like benzodiazepines and barbiturates.
• Receptor Modulation:
• Benzodiazepines bind to a modulatory site on GABA-A receptors → enhance GABA’s inhibitory effect (more Cl⁻ enters).
• They don’t open the channel alone—GABA must be present.
• Barbiturates can both enhance GABA and directly open the channel at high doses, making overdose more likely.

•	Orphan Receptors (孤儿受体):
•	Receptors with no known endogenous ligand (natural brain chemical that binds to them).
•	GABA-A receptor subtypes were once considered orphans until ligands like neurosteroids were discovered.
•	Neurosteroids (神经类固醇):
•	Naturally produced in the brain, derived from steroid hormones.
•	Modulate GABA-A receptor activity by binding to unique sites.
•	Can enhance GABAergic inhibition, producing anxiolytic and calming effects.
•	Allopregnanolone (别孕烯醇酮):
•	A type of neurosteroid.
•	Potent positive modulator of GABA-A receptors.
•	Linked to stress regulation, mood, and postpartum depression (new drugs like brexanolone mimic this action).

Key Takeaway:
• GABA-A receptors inhibit neural activity via Cl⁻ influx. Benzodiazepines, neurosteroids (like allopregnanolone), and other modulators enhance GABA’s effects. Orphan receptors are those with unknown ligands—some were later found to respond to neurosteroids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are opiates, and what do we need to know about opium, morphine, heroin, and fentanyl?

A

Key Findings:
• Opiates (鸦片类药物):
• Drugs derived from opium poppy (罂粟) or synthetically made to mimic endogenous opioid peptides.
• Bind to opioid receptors in the brain and spinal cord, especially in pain and reward circuits.

•	Key Types:
•	Opium (鸦片):
•	Natural extract from poppy. Contains morphine and codeine.
•	Morphine (吗啡):
•	A potent analgesic (镇痛药). Used medically to relieve severe pain.
•	Heroin (海洛因):
•	Chemically modified from morphine.
•	Crosses the blood-brain barrier quickly, creating intense euphoria.
•	Highly addictive and illegal in most places.
•	Fentanyl (芬太尼) (30-40 times stronger than heroin):
•	Synthetic opioid. Up to 50–100 times more potent than morphine.
•	Small dosage = high overdose risk.
•	Accidental fentanyl exposure is a major cause of overdose deaths, often mixed into heroin or counterfeit pills unknowingly.


•	Effects:
•	Pain relief, euphoria, sedation
•	Long-term use leads to tolerance, dependence, and withdrawal
•	Overdose causes respiratory depression → death

Key Takeaway:
• Opiates like morphine, heroin, and fentanyl are powerful painkillers but carry high risk for addiction and overdose—especially with potent synthetic opioids like fentanyl.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are opioid receptors, what is the role of the periaqueductal gray (PAG), and what are endogenous opioids?

A

Key Findings:
• Opioid Receptors (阿片受体):
• G-protein-coupled receptors found throughout the brain, spinal cord, and digestive system.
• Three main subtypes:
• Mu (μ) → pain relief, euphoria, respiratory suppression.
• Delta (δ) → mood regulation, pain modulation.
• Kappa (κ) → pain relief, dysphoria, hallucinations.
• Activated by both natural (e.g., morphine) and endogenous opioids.

•	Endogenous Opioids (内源性阿片肽):
•	Naturally produced peptides in the body that bind to opioid receptors.
•	Include:
•	Enkephalins (脑啡肽)
•	Endorphins (内啡肽)
•	Dynorphins (强啡肽)
•	Involved in pain suppression, stress response, reward, and mood.


•	Periaqueductal Gray (PAG, 导水管周围灰质):
•	A region in the midbrain that plays a central role in pain modulation.
•	Rich in opioid receptors.
•	Activating PAG (e.g., via opioids or electrical stimulation) produces strong analgesic effects by inhibiting pain signals at the spinal level.

Key Takeaway:
• Opioid receptors mediate pain relief and reward by responding to both drugs and endogenous opioids like endorphins. The periaqueductal gray is a key brain area where opioid action suppresses pain perception.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the main types of opioid receptors, what do opioid antagonists do, and how does naltrexone work?

A

Key Findings:
• Three Main Opioid Receptors
• All are metabotropic receptors (G-protein-coupled).
• Mu (μ) receptor: Responsible for pain relief, euphoria, respiratory depression.
• Delta (δ) receptor: Involved in mood regulation and some pain modulation.
• Kappa (κ) receptor: Produces pain relief but can also cause dysphoria and hallucinations.
• Opioid Antagonists (阿片拮抗剂)
• Bind to opioid receptors but do not activate them.
• Instead, they block the effects of opioids, including both drugs (like heroin) and endogenous peptides.
• Used to treat overdose and dependence.
• Naltrexone
• A long-lasting opioid receptor antagonist.
• Blocks all three receptor types, especially mu receptors.
• Used to:
• Treat opioid addiction by preventing drug-induced euphoria
• Help maintain abstinence
• Sometimes also used for alcohol dependence

Key Takeaway:
• Opioids act on three metabotropic receptors: mu, delta, and kappa. Antagonists like naltrexone block these receptors to prevent the effects of opioids, making them useful for treating addiction and overdose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is cannabis, and what are the functions of its active ingredients THC and CBD?

A

Key Findings:
• Cannabis (大麻)
• A psychoactive plant used for recreational, medicinal, and cultural purposes.
• Acts on the endocannabinoid system, which regulates mood, appetite, pain, and memory.
• Main Active Ingredients
• Δ⁹-Tetrahydrocannabinol (THC)
• Primary psychoactive component.
• Binds to CB1 receptors in the brain.
• Produces effects like euphoria, relaxation, altered perception, and impaired memory.
• Cannabidiol (CBD)
• Non-psychoactive compound.
• Interacts with multiple receptor systems, including CB1 and serotonin receptors, but does not cause a high.
• Known for anti-anxiety, anti-inflammatory, and seizure-reducing properties.
• Often used in medical cannabis.

Key Takeaway:
• Cannabis contains THC, which causes psychoactive effects, and CBD, which is non-intoxicating and has therapeutic benefits. Both act on the brain’s cannabinoid system but with different effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are CB1 and CB2 receptors, and how do they differ in location and function?

A

Key Findings:
• CB1 Receptors
• Found mainly in the central nervous system—especially in the cortex, hippocampus, basal ganglia, and cerebellum.
• Responsible for the psychoactive effects of THC.
• Involved in mood regulation, memory, appetite, pain sensation, and motor control.
• THC is a partial agonist at CB1 receptors.
• CB2 Receptors
• Found mostly in the immune system and peripheral tissues (e.g., spleen, white blood cells).
• Involved in modulating inflammation and immune responses.
• Less associated with psychoactive effects.
• Targeted more often for medical or therapeutic uses (e.g., autoimmune diseases, chronic pain).

Key Takeaway:
• CB1 receptors are mainly in the brain and mediate THC’s psychoactive effects, while CB2 receptors are found in immune cells and are involved in inflammation and immune regulation.

20
Q

What are stimulants, and how do nicotine and cocaine affect the nervous system?

A

Key Findings:
• Stimulants (兴奋剂)
• Drugs that increase activity in the central nervous system.
• Enhance alertness, arousal, attention, and often cause euphoria.
• Act by increasing neurotransmitter levels, especially dopamine, norepinephrine, and acetylcholine.

•	Nicotine (尼古丁)
•	Found in tobacco.
•	Agonist at nicotinic acetylcholine receptors (nAChRs).
•	Increases dopamine release, especially in reward circuits.
•	Causes mild stimulation, increased focus, and is highly addictive.
•	Chronic use → tolerance, dependence, and withdrawal.
•	Cocaine (可卡因)
•	Blocks reuptake of dopamine, norepinephrine, and serotonin.
•	Leads to a strong buildup of these neurotransmitters in the synaptic cleft.
•	Causes intense euphoria, energy, and confidence, followed by a crash.
•	Highly addictive, with strong risk for cardiac issues and neurotoxicity.

Key Takeaway:
• Stimulants like nicotine and cocaine increase nervous system activity by boosting neurotransmitter levels. Nicotine acts on acetylcholine receptors, while cocaine blocks reuptake of dopamine and other monoamines, leading to powerful and addictive effects.

21
Q

What are tolerance and sensitization to cocaine, and what does dual dependence mean?

A

Key Findings:
• Tolerance to Cocaine (耐受性)
• With repeated use, the body becomes less responsive to some of cocaine’s effects.
• Especially seen in euphoric or mood-related effects.
• Leads users to increase the dose to chase the same high.
• Sensitization to Cocaine (敏化作用)
• In contrast, some effects—especially motor stimulation, anxiety, or craving—can become more intense over time, even with lower doses.
• Sensitization may persist even after drug use stops, increasing the risk of relapse.
• Dual Dependence (双重依赖)
• Occurs when someone becomes dependent on more than one drug, often because the drugs are used together to balance or amplify effects.
• Example: Cocaine and heroin (speedball)
• Cocaine provides stimulation; heroin calms the crash.
• This combination is especially dangerous and increases the risk of overdose.

Key Takeaway:
• Cocaine can lead to both tolerance (reduced euphoric response) and sensitization (increased craving or motor effects). Dual dependence involves addiction to two drugs, often used together to manage or intensify effects.

22
Q

How can a person become tolerant and sensitized to cocaine at the same time?

A

Key Findings:
• Different effects of a drug involve different brain systems.
• Cocaine affects multiple neurotransmitters and brain regions (e.g., reward, motor, stress systems).
• Tolerance and sensitization can develop in parallel but in different circuits.
• Tolerance
• Happens when repeated use leads to reduced sensitivity to certain effects, like euphoria.
• This is due to dopamine receptor downregulation or homeostatic adaptation in reward circuits.
• Sensitization
• Happens when other effects (e.g., motor stimulation, craving, or anxiety) become stronger over time.
• Involves changes in other pathways, like the mesolimbic dopamine system or amygdala.
• Sensitization is especially linked to cue-triggered craving and relapse risk.

Key Takeaway:
• A person can be tolerant to cocaine’s euphoric effects while sensitized to its craving or behavioral effects because different neural circuits adapt in opposite ways to repeated drug exposure.

23
Q

How can tolerance and sensitization happen at the same time—are different brain regions involved?

A

Tolerance
• Mainly involves the mesocorticolimbic dopamine system, especially:
• Nucleus accumbens
• Prefrontal cortex
• With repeated cocaine use, these areas reduce dopamine receptor sensitivity or decrease dopamine release, leading to weakened euphoria over time.
• Sensitization
• More strongly associated with:
• Ventral tegmental area (VTA)
• Amygdala
• Striatum
• These areas become more reactive to drug cues or drug-related stimuli, increasing motivation, craving, and drug-seeking behavior.
• Even when the “high” weakens, the urge and behavioral drive intensify.

Key Takeaway:
• Tolerance and sensitization occur in different brain circuits—reward-related areas develop tolerance to the pleasurable effects, while cue and habit-related areas become sensitized, heightening craving and relapse risk.

24
Q

How can a single drug like cocaine cause both tolerance and sensitization?

A

Key Findings:
• One drug, multiple effects
• Cocaine affects many neurotransmitters and brain regions.
• Each effect (e.g., euphoria, craving, movement, stress) is linked to different circuits.
• Tolerance develops
• In reward systems like the nucleus accumbens → repeated use weakens the high.
• Brain adjusts by reducing dopamine response.
• Sensitization develops
• In motivation and craving systems like the amygdala, VTA, and prefrontal cortex.
• These areas become more sensitive, making you crave more even if the drug feels weaker.

Key Takeaway:
• One drug can have multiple effects by acting on different brain regions. Cocaine weakens the reward (“tolerance”) but strengthens craving (“sensitization”) at the same time.

25
How do dopamine receptor types and pathways explain addictive behavior and why one drug can cause opposite effects?
Key Findings: • Two Types of Dopamine Receptors • D1 receptors → Excitatory, involved in the direct pathway → facilitates actions (“Go”). • D2 receptors → Inhibitory, involved in the indirect pathway → suppresses actions (“No-go”). • Dopamine’s Role in These Pathways • Enhances direct pathway (via D1) → promotes reward-seeking and goal-directed behavior. • Inhibits indirect pathway (via D2) → reduces behavioral inhibition. • Together, this leads to stronger initiation of rewarding actions and less control over stopping them. • In Addiction • With chronic drug use, dopamine signaling becomes dysregulated. • Direct pathway becomes overactive, reinforcing drug-seeking habits. • Indirect pathway becomes weakened, reducing impulse control and the ability to stop. • This imbalance may explain why people persistently engage in drug use despite negative consequences. Key Takeaway: • Dopamine affects two opposing motor/motivation circuits via different receptors. In addiction, overactivation of the “Go” system and underactivation of the “No-go” system helps explain compulsive drug-seeking behavior.
26
27
Can different types of receptors lead to different effects from the same drug?
Key Findings: • Yes. A single neurotransmitter (like dopamine) can act on different receptor types, each triggering distinct effects. • For dopamine: • D1 receptors (excitatory) → enhance the direct pathway → promotes action and reward-seeking. • D2 receptors (inhibitory) → affect the indirect pathway → reduces behavioral inhibition. • So, a drug that increases dopamine (like cocaine) can simultaneously: • Increase motivation and reward-driven behavior • Reduce impulse control Key Takeaway: • One drug can produce different—and even opposing—effects by acting on different receptor types in the brain.
28
What are amphetamine and methamphetamine, and how do they affect the brain?
Key Findings: • Amphetamine (安非他命) • A potent stimulant that increases dopamine, norepinephrine, and serotonin levels in the brain. • Works by: • Blocking reuptake of these neurotransmitters • Reversing transporters to cause massive neurotransmitter release into the synapse • Used medically for ADHD (e.g., Adderall) and narcolepsy. • Methamphetamine (甲基苯丙胺) • A stronger, more addictive version of amphetamine. • Crosses the blood-brain barrier faster → produces more intense and longer-lasting effects. • Causes extreme euphoria, energy, but also rapid tolerance, dependence, and neurotoxicity. • Chronic use can lead to dopamine system damage, psychosis, and cognitive decline. Key Takeaway: • Amphetamine and methamphetamine are powerful stimulants that boost dopamine and other monoamines. Methamphetamine acts faster and stronger, making it highly addictive and neurotoxic.
29
What are the short-term and long-term effects of amphetamine use?
Key Findings: • Short-Term Effects: • Increased alertness, energy, euphoria • Reduced appetite • Increased heart rate and blood pressure • Enhanced focus and confidence (often used medically for ADHD) • Long-Term Use: • Tolerance and dependence • Neurotoxicity → especially to dopamine neurons • Psychiatric symptoms: anxiety, paranoia, hallucinations • Cognitive deficits: memory loss, impaired attention • Physical effects: weight loss, dental issues (especially in meth use) Key Takeaway: • Amphetamines provide short-term stimulation and focus but can lead to addiction, brain damage, and mental health issues with long-term use.
30
What are the effects of alcohol, and how does it act on GABA-A receptors and dopamine?
Key Findings: • Alcohol (乙醇) is a central nervous system depressant. • Causes relaxation, reduced anxiety, slowed reflexes, and impaired judgment. • High doses can lead to sedation, unconsciousness, or death from respiratory depression. ⸻ • Mechanism 1 – GABA-A Receptor Activation • Alcohol enhances GABA-A receptor activity. • GABA-A is an inhibitory receptor that lets Cl⁻ ions into neurons. • This hyperpolarizes the cell, making it less likely to fire → produces calming and sedative effects. • Mechanism 2 – Dopamine Release • Alcohol indirectly increases dopamine release in the nucleus accumbens (reward center). • Contributes to feelings of pleasure and reinforcement, which support addictive potential. Key Takeaway: • Alcohol depresses brain activity by enhancing GABA-A inhibition and indirectly increasing dopamine in reward pathways, leading to both sedation and reinforcement.
31
What does the brain volume study reveal about abstainers, relapsers, and light drinkers after one week without alcohol?
Key Findings: • After one week of abstinence, researchers measured average brain volume change among three groups: • Abstainers (people who stayed off alcohol) • Relapsers (those who returned to heavy drinking) • Light drinkers • Results: • Abstainers showed significant brain volume recovery after just one week. • Relapsers showed little to no recovery, or continued brain volume loss. • Light drinkers remained relatively stable. • Suggests that the brain can begin to heal quickly when drinking stops— but relapse halts or reverses recovery. Key Takeaway: • The brain shows early signs of volume recovery after stopping alcohol, but relapse prevents healing—highlighting how fast alcohol affects brain structure and how important sustained abstinence is.
32
What are hallucinogens, and how does LSD affect the brain?
Key Findings: • Hallucinogens (致幻剂) • Drugs that cause sensory distortions, altered perception, and sometimes profound changes in thought and emotion. • Common effects: visual or auditory hallucinations, time distortion, synesthesia, ego dissolution. • Examples: LSD, psilocybin (magic mushrooms), mescaline. • LSD (Lysergic acid diethylamide) • A potent synthetic hallucinogen. • Primarily acts as a serotonin (5-HT2A) receptor agonist, especially in the visual cortex and default mode network. • Causes intense visual imagery, disrupted sense of self, and emotionally vivid experiences. • Non-addictive, but can lead to tolerance and psychological distress or “bad trips”. Key Takeaway: • Hallucinogens like LSD alter perception and consciousness by acting on serotonin receptors, especially in sensory and integrative brain regions. LSD produces vivid experiences without being physically addictive.
33
What does the painting shown in the slide reveal about LSD’s effect on the brain?
Key Findings: • The slide shows a visual representation (brain “painting”) based on fMRI scans of the brain under LSD. • It highlights increased global connectivity—brain regions that usually operate independently become more interconnected. • This hyper-connectivity helps explain: • Sensory blending (e.g., synesthesia) • Unusual thoughts and visuals • Altered sense of self or ego dissolution • The painting reflects how LSD leads to a less constrained, more chaotic and integrated brain state, unlike the normal resting brain where regions are more segregated. Key Takeaway: • The fMRI-based painting shows that LSD increases cross-talk between brain regions, helping explain its intense perceptual and emotional effects.
34
How widespread is substance abuse, and what are its social consequences?
Key Findings: • Substance Abuse and Addiction affect millions of people worldwide. • In the U.S. alone, tens of millions struggle with alcohol, tobacco, or drug addiction each year. • Addiction is recognized as a chronic brain disorder, not just a moral failing. • Social Costs include: • Healthcare expenses (treatment, hospitalizations) • Lost productivity (missed work, unemployment) • Crime and legal system burden (drug-related arrests, incarceration) • Family and relationship breakdown • Costs to education and welfare systems • Economic burden in the U.S. is estimated in the hundreds of billions of dollars per year. Key Takeaway: • Substance abuse and addiction affect millions and carry enormous personal, social, and economic costs—impacting public health, families, and society at large.
35
What are the moral and disease models of drug abuse, and how do they relate to understanding addiction?
Key Findings: • Moral Model (道德模型) • Views drug abuse as a personal failure or moral weakness. • Belief: people choose to use drugs and should be punished or shamed. • Often used in stigmatizing attitudes and punitive policies. • Does not account for biological, psychological, or social factors. • Disease Model (疾病模型) • Treats addiction as a chronic medical condition involving brain changes. • Emphasizes genetics, neurobiology, and environmental influences. • Supports treatment, rehabilitation, and long-term support rather than punishment. • Widely accepted by modern neuroscience and psychiatry. • Addiction (成瘾) • A brain disorder marked by compulsive drug seeking and use, despite negative consequences. • Involves dysregulation of reward and control systems (e.g., dopamine pathways). • Can lead to relapse even after long abstinence. Key Takeaway: • The moral model blames the individual, while the disease model explains addiction as a medical issue rooted in brain dysfunction—shaping how society responds to and treats drug abuse.
36
What is the physical dependence model of drug abuse?
Key Findings: • Physical Dependence Model (生理依赖模型) • Suggests that people continue drug use to avoid withdrawal symptoms. • Withdrawal = unpleasant physical or emotional symptoms that occur when drug use stops. • Examples: pain, anxiety, nausea, irritability, sweating. • The model sees addiction as a cycle: 1. Drug use 2. Tolerance 3. Withdrawal 4. Continued use to relieve withdrawal • Limitations: • Doesn’t explain relapse after withdrawal ends. • Some drugs (e.g., cocaine) have mild withdrawal but are still highly addictive. • Psychological and behavioral components also play a major role in addiction. Key Takeaway: • The physical dependence model explains addiction as driven by avoiding withdrawal symptoms, but it cannot fully explain long-term craving or relapse—suggesting addiction is more than just physical dependence.
37
What did the rat self-administration experiment reveal about addiction and the limitations of the physical dependence model?
Key Findings: • The Experiment: • Rats were trained to press a lever to self-administer a drug (e.g., heroin or cocaine) directly into their bloodstream. • They continued pressing the lever repeatedly, even without any withdrawal symptoms present. • Some rats chose drugs over food or social interaction, highlighting compulsive drug-seeking. • What It Shows: • Supports the Positive Reward Model (正性奖赏模型): • Drug use is driven by the pleasurable, reinforcing effects of the drug (the “high”). • Addiction is more about seeking reward, not just avoiding withdrawal. • Challenges the Physical Dependence Model: • Rats were not using the drug to escape withdrawal—they were motivated by the drug’s rewarding effects, even in its absence. Key Takeaway: • The rat self-administration study supports the positive reward model—showing that addiction is driven by reward-seeking behavior, not merely by avoiding withdrawal.
38
What roles do dopamine and the nucleus accumbens play in addiction?
Key Findings: • Dopamine (多巴胺) • A key neurotransmitter involved in reward, motivation, and reinforcement. • Released in response to natural rewards (e.g., food, social interaction) and drugs of abuse. • Nucleus Accumbens (伏隔核) • A core part of the mesolimbic dopamine system, often called the brain’s reward center. • Receives dopamine input from the ventral tegmental area (VTA). • Activation of the nucleus accumbens reinforces behaviors that lead to dopamine release. • In Addiction: • Drugs like cocaine, nicotine, opioids, and alcohol cause excessive dopamine release in the nucleus accumbens. • This leads to strong reinforcement, promoting repeated use. • Over time, the brain becomes less sensitive to natural rewards, increasing reliance on drugs. Key Takeaway: • Dopamine release in the nucleus accumbens reinforces drug-taking behavior, making it a central mechanism in the development of addiction.
39
What does Pascoli et al. (2015) show about the sufficiency of dopamine pathway activation in addiction?
Key Findings: • Purpose of the Study: • To test whether activating dopamine pathways alone is sufficient to drive drug-seeking behavior. • Method (Using Optogenetics): • Researchers artificially stimulated dopamine neurons in the VTA that project to the nucleus accumbens. • Mice were given a lever that would trigger this stimulation. • Results: • Mice learned to press the lever repeatedly, even in the absence of any actual drug. • The behavior mimicked compulsive drug-seeking, showing addiction-like behavior. • Conclusion: • Artificial dopamine activation alone was sufficient to drive reinforcement and habit formation. • Supports the idea that dopamine release in the reward circuit can itself create addictive behavior. Key Takeaway: • Pascoli et al. (2015) showed that directly activating dopamine pathways is sufficient to trigger drug-like reinforcement, proving dopamine’s central role in driving addiction.
40
What does the Pascoli et al. (2015) experiment show about behavior that resists punishment?
Key Findings: • Punishment Phase: • After mice learned to press a lever for dopamine stimulation, researchers introduced a mild foot shock each time the lever was pressed. • This tested whether mice would stop the behavior when facing negative consequences. • Results – Resistance to Punishment: • Despite the foot shock, many mice continued pressing the lever for dopamine pathway stimulation. • This reflects compulsive-like behavior — continuing to seek reward even when it causes harm. • Mimics real-life addiction, where individuals persist in drug use despite negative outcomes (e.g., health issues, social harm). Key Takeaway: • Pascoli et al. (2015) showed that dopamine-driven behavior can persist even in the face of punishment, supporting the idea that addiction involves compulsive and punishment-resistant brain mechanisms.
41
What does the Pascoli et al. (2015) study tell us about relapse behavior, and what was the experimental baseline?
Key Findings: • Baseline (基线设定): • Mice were trained to press a lever to receive optogenetic activation of dopamine neurons (VTA to nucleus accumbens). • Once they learned this behavior, lever pressing was extinguished by removing the stimulation (no reward when pressing). • This created a baseline of no responding, simulating abstinence or recovery. • Relapse Test: • After extinction, the researchers reactivated the dopamine pathway briefly. • This reinstated the lever-pressing behavior, even though no actual drug or reward was given. • Mice relapsed into the same compulsive seeking, triggered by dopamine activation alone. • Implication: • Demonstrates that dopamine pathway reactivation is sufficient to cause relapse. • Mimics how drug cues or stress might reawaken drug-seeking in human addiction. • Suggests that addiction is deeply encoded in brain circuitry, not just a behavioral habit. Key Takeaway: • Pascoli et al. (2015) showed that even after extinction, reactivating dopamine pathways can trigger relapse, highlighting how vulnerable the brain remains to falling back into addictive behaviors.
42
What are the key ideas from Berridge and Robinson’s Incentive Sensitization Theory of addiction?
Key Findings: • “Wanting” ≠ “Liking” • Wanting refers to motivation and craving, often driven by cues and impulsivity, not conscious choice. • Liking refers to the pleasurable sensation itself. • You can want something without liking it (e.g., in addiction). • Two types of “wanting”: • Goal-directed wanting: Based on conscious intention. • Cue-triggered wanting: Automatic, impulsive, driven by sensitized brain pathways. • Role of Dopamine • Dopamine depletion doesn’t reduce pleasure (liking) but does reduce motivation to seek reward (wanting). • Dopamine is released in the mesolimbic system (e.g., VTA → nucleus accumbens) and becomes sensitized by repeated cue exposure. • Incentive Sensitization • Cues (not drugs themselves) become hyper-salient over time. • Triggers intense “wanting” responses, even if the drug no longer brings pleasure. • Explains relapse, craving, and compulsive use. • Beyond Drugs • Same mechanism applies to gambling, porn, food addiction, etc. • Tolerance develops to the drug’s effect, but sensitization develops to environmental cues. Key Takeaway: • Incentive Sensitization Theory explains addiction as cue-triggered “wanting” that is independent of pleasure. Dopamine sensitization drives compulsive behavior across drug and non-drug addictions.
43
What does the brain disease model of addiction propose, and what are its key neurobiological findings and treatment implications?
Key Findings: • Addiction = Brain Disease • Addiction causes long-term neuroplastic changes in key brain circuits, not just behavioral choices. • It affects regions for reward (dopamine, glutamate systems), stress, and executive control (prefrontal cortex). • Three Key Stages of Addiction: 1. Binge/Intoxication – drug causes strong dopamine release, cues become conditioned. 2. Withdrawal/Negative Affect – natural rewards lose meaning; stress systems (amygdala) become overactive. 3. Preoccupation/Anticipation (Craving) – prefrontal cortex function is impaired, leading to poor decision-making and loss of control. • Cue-Triggered Dopamine: • Over time, dopamine spikes shift from drug to drug-predictive cues, driving compulsive seeking behavior. • Reduced Dopamine with Addiction: • In addicted brains, drugs cause less dopamine release than in healthy brains → explains tolerance, less pleasure, reduced motivation for normal rewards. • Neuroplasticity: • Long-term drug use alters glutamate and dopamine signaling, especially in prefrontal cortex, amygdala, hippocampus, and nucleus accumbens. • Treatment and Prevention: • Emphasizes medical and behavioral interventions over punishment. • Medications (e.g., methadone, buprenorphine, naltrexone) and behavioral therapy can restore function. • Early prevention should focus on teaching self-regulation, stress control, and emotional development, especially in adolescents. • Stigma and Policy: • Framing addiction as a disease helps reduce stigma and supports policies that promote treatment over incarceration. • Supports insurance parity laws and integration of addiction care into primary healthcare. Key Takeaway: • Addiction alters brain circuits involved in reward, stress, and self-control. Framing it as a brain disease shifts the focus from moral blame to science-based treatment and recovery support.
44
Question: What are the four major models of addiction, and what does the incentive sensitization theory add to our understanding?
Key Findings: • 1. Disease Model(疾病模型) • Addiction is a brain disease involving structural and functional changes. • Advocates medical treatment and reducing stigma. • 2. Moral Model(道德模型) • Addiction is due to poor moral choices or lack of willpower. • Leads to stigma, shame, and punitive responses, not support. • 3. Physical Dependence Model(生理依赖模型) • Focuses on withdrawal symptoms as the reason people continue using drugs. • Addiction = avoiding discomfort. • 4. Positive Reward Model(奖赏模型) • Drugs activate the reward system, causing pleasure that reinforces continued use.
45
Incentive Sensitization Theory(激励敏感化理论)
With repeated use, the reward pathway becomes sensitized, especially to external cues associated with the drug. • This causes increased “wanting” (motivation to seek) without increased “liking” (pleasure). • Explains craving and relapse, even when the drug no longer feels good. Key Takeaway: • Addiction is best explained by combining brain-based models (e.g., disease, sensitization) and motivational mechanisms. “Wanting” can persist without “liking,” driven by cue-triggered dopamine release.